Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
BABAM2	"BRCC4, BRCC45, BRE"	ENSG00000158019	"BRISC and BRCA1 A complex member 2"	Q9NXR7	2	27889941-28338901	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 172.1"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 71.3;monocytes: 45.1;Proximal tubular cells: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017926, HPA048867"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA017926: AB_1845443, HPA048867: "	"unprognostic (1.28e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.22e-2)"	14.5	172.1	11.7	11.4	19.3	16.9	12.3	9.6	21.3	14.3	11.2	11.3	14.2	8.8	23.2	17.1	12.0	15.5	15.6	25.2	12.5	12.7	25.0	17.1	11.5	18.9	9.9	13.8	16.7	14.5	21.8	23.5	11.6	13.4	11.8	13.1	16.3	10.3	15.6	28.7	11.5	11.1	18.2	9.1	16.7	11.6	26.3	6.7	13.9	11.9	13.6	15.7	14.2	11.8	23.5	39.7	38.6	30.2	24.8	31.7	23.6	14.6	16.1	13.1	13.7	16.9	22.7	12.9	7.4	18.8	14.1	14.6	13.7	15.1	16.6	25.1	17.9	11.3	9.8	10.6	19.4	20.7	14.0	14.0	19.9	7.0	15.2	24.5	10.3	16.2	55.4	17.0	19.6	20.4	17.7	14.9	15.7	10.1	18.3	19.5	12.3	12.0	12.6	9.9	19.3	10.6	11.1	20.8	16.0	40.5	7.7	8.6	13.7	8.7	15.5	14.8	13.9	11.0	13.7	12.0	13.4	17.9	12.3	10.1	20.8	20.2	21.8	24.9	28.4	14.0	38.6	30.2	12.3	28.5	24.0	31.7	23.5	24.2	26.8	39.7	17.9	23.1	22.0	16.0	24.8	23.3	15.8	27.8	23.6	11.7	19.3	9.6	21.3	12.5	12.7	9.9	13.8	13.4	6.7	3.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	16.0	10.3	38.4	0.0	38.1	71.3	42.4	0.0	0.0	0.0	0.0	39.2	30.4	0.0	0.0	29.1	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	45.1	0.0	0.0	21.6	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911172-16037282	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm		NA	NA		180000	Nucleoplasm		"HPA055897: AB_2682963"	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (3.66e-2)"	20.3	12.0	10.5	10.8	10.8	7.5	11.5	5.2	7.7	11.3	30.3	11.4	12.7	20.2	21.5	14.7	20.0	8.2	11.1	11.7	10.1	9.1	40.9	51.5	13.6	14.1	12.5	6.5	5.8	16.9	6.6	27.5	12.3	11.3	9.2	21.2	11.0	11.4	11.3	15.3	12.4	46.7	10.4	14.6	14.6	10.5	5.5	11.0	13.8	26.6	16.7	14.3	10.1	13.1	12.4	30.2	14.1	28.2	17.1	14.9	15.7	19.0	15.8	12.4	10.9	8.4	19.2	25.4	11.1	10.5	15.2	19.5	19.0	35.4	13.0	9.9	14.2	13.7	13.5	13.4	14.3	27.0	21.7	7.8	11.5	7.9	17.9	12.1	12.1	7.8	12.8	16.6	12.4	25.5	12.9	21.9	11.1	1.6	4.0	27.6	7.0	9.0	10.1	27.0	10.7	7.8	13.8	27.2	8.1	38.1	6.9	9.0	15.3	21.0	7.0	21.9	51.1	37.9	15.2	21.6	16.2	10.7	7.4	11.9	4.3	6.3	22.4	20.8	12.2	11.9	5.4	24.4	14.1	7.2	27.1	7.9	12.4	7.8	7.7	30.2	11.4	8.6	6.9	6.5	17.1	28.2	16.5	14.9	15.7	10.5	10.8	5.2	7.7	10.1	9.1	12.5	6.5	11.3	11.0	41.7	25.0	18.6	24.3	26.1	5.0	11.4	22.9	21.4	22.7	12.2	13.7	54.5	92.9	55.2	33.8	25.2	49.7	0.0	52.2	57.8	21.3	17.5	8.1	44.5	53.2	3.2	25.4	30.7	32.6	3.0	22.7	32.0	69.2	55.9	43.0	20.9	60.6	45.0	28.7	104.3	25.2	6.5	18.6	5.0	14.7	22.6	59.6	10.0	39.9	24.7
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"	"Cell line enhanced"	"Detected in all"		"A549: 229.1;MCF7: 86.9"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.7	229.1	4.7	18.1	19.9	27.1	4.2	11.0	31.5	11.2	19.4	10.5	5.9	10.1	17.1	25.0	45.4	14.0	7.3	18.6	5.8	10.3	5.1	10.7	51.9	23.6	38.8	10.8	36.9	13.1	5.5	21.9	4.7	17.6	23.3	7.5	6.4	4.4	20.3	86.9	6.9	7.7	3.4	50.2	17.0	6.8	2.7	11.1	33.8	19.6	4.8	6.0	10.9	42.8	9.2	6.4	6.4	9.0	27.6	7.1	25.0	9.9	16.9	5.4	7.0	17.4	19.7	7.2	14.5	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5	0.0	17.1	21.3	18.5	11.1	5.7	0.8	20.4	4.0	0.0	10.4	17.7	26.0	24.9	35.4	8.1	12.8	18.6	23.3	25.6	33.4	18.8	16.7	38.0	0.8	41.6	31.8	9.1	16.0	63.9	10.4	24.2	25.3	18.6	130.8	9.6	11.9	34.1	9.1	15.2	11.9	24.6	6.5	12.3	10.1	34.9	12.0	30.3	39.5	9.9	26.5
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.9	3.2	2.8	10.5	29.2	33.5	2.7	3.9	9.8	2.9	4.6	0.6	8.1	4.3	4.6	6.1	3.7	4.1	0.7	1.9	4.3	12.9	0.9	0.0	1.0	2.6	16.3	1.4	1.7	32.9	3.8	7.0	4.6	6.5	13.4	2.4	1.1	7.5	5.7	2.3	1.5	3.2	1.5	2.9	1.9	0.5	0.3	3.6	3.8	1.6	0.9	5.0	5.2	4.1	4.9	2.0	3.1	7.0	13.3	10.1	1.7	2.5	1.1	10.0	2.9	1.0	16.9	6.3	6.4	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5	23.8	29.3	11.2	11.1	12.7	18.1	13.0	58.6	10.7	12.5	19.2	25.5	9.0	0.0	15.8	0.8	14.7	15.1	0.0	18.5	6.5	24.0	16.2	3.5	132.8	11.5	15.9	7.5	17.8	18.0	1.5	44.5	10.3	11.8	64.9	15.2	11.2	20.1	17.5	34.6	8.2	11.5	0.0	9.2	4.7	4.6	11.2	4.9	13.8	24.1	11.4
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 359.6;Proximal tubular cells: 948.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;Hep G2: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		NA	NA		320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	14.0	10.7	1.7	6.4	1.2	0.3	1.4	1.0	0.6	1.3	0.8	5.1	3.1	2.1	3.4	0.0	1.5	6.2	5.5	1.8	0.4	5.0	10.1	18.6	2.8	27.1	0.6	2.5	2.2	0.1	0.8	1.6	0.1	0.7	1.2	3.0	3.3	3.6	0.1	9.1	3.0	2.0	2.3	12.7	4.2	10.7	0.8	11.8	1.6	1.7	6.0	9.4	2.1	3.6	4.0	0.6	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.9	3.6	1.8	6.1	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6	3.0	5.9	9.6	2.3	3.2	3.6	1.9	15.3	0.0	1.2	38.4	2.0	2.6	109.5	3.1	0.8	5.8	12.3	0.0	2.6	3.6	1.9	0.9	4.6	359.6	7.5	6.4	5.8	6.7	13.2	3.6	1.7	5.8	8.5	1.0	5.9	8.5	2.7	1.7	1.4	948.1	5.2	0.0	4.5	0.9	6.8	5.9	7.9	4.6	14.3	1.0
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 368.5;Late spermatids: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.8	67.3	4.5	0.1	4.5	9.5	58.8	29.8	10.7	30.2	36.4	70.9	50.9	5.7	23.8	21.4	28.0	38.9	23.0	46.5	31.8	16.1	17.7	20.7	32.4	3.8	10.7	8.3	34.8	4.4	10.5	31.7	15.8	45.8	58.1	24.3	5.7	0.2	33.4	37.4	28.3	9.0	7.4	21.0	23.6	22.2	7.5	23.1	32.7	18.8	12.4	10.7	21.1	18.0	26.4	56.5	14.8	13.1	69.9	20.6	11.1	62.1	32.4	32.7	29.5	20.5	52.9	16.0	12.6	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8	3.0	6.5	16.7	44.9	25.4	38.3	113.1	10.2	21.4	27.3	61.1	51.1	2.1	36.5	101.2	368.5	28.8	46.6	0.0	9.2	171.9	17.4	35.9	56.4	0.8	28.5	39.7	35.7	14.1	12.6	396.4	6.9	16.2	18.6	21.6	19.5	104.9	80.1	28.1	6.3	2.1	105.7	12.9	30.8	39.9	3.2	19.7	22.2	27.3	24.5	48.7
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 204.0;monocytes: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Cell line enhanced"	"Detected in all"		"A549: 181.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	23.1	181.8	45.3	48.7	69.0	42.7	9.8	15.7	27.8	21.8	29.8	26.6	26.7	22.8	19.4	16.1	29.9	19.7	33.1	28.1	14.7	15.7	28.9	30.8	32.7	55.9	21.0	50.8	34.2	30.4	14.1	34.4	8.5	27.8	51.4	32.0	41.0	20.2	27.8	26.3	41.9	25.5	27.2	31.8	16.0	32.5	41.6	41.9	30.4	12.5	24.4	21.3	13.4	21.3	18.5	31.2	23.5	43.6	48.1	11.5	20.4	13.7	17.3	15.3	27.9	40.8	25.1	55.2	10.3	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4	17.9	31.2	16.0	28.9	11.6	7.9	9.5	50.9	17.4	23.9	19.2	17.7	114.8	44.7	45.3	7.1	17.5	32.9	0.0	35.1	31.4	28.8	33.1	24.4	48.2	117.8	1.6	22.4	16.0	204.0	9.8	15.8	88.3	16.9	212.8	23.7	12.9	39.9	25.9	9.9	40.3	16.4	19.4	9.8	33.4	37.9	14.4	68.0	16.0	44.1	66.7
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.9	17.1	10.7	7.3	16.5	27.4	20.6	13.0	21.2	13.1	16.9	8.1	28.7	21.0	14.6	20.3	9.3	13.1	6.0	20.3	3.9	10.4	23.5	9.9	7.9	14.5	28.3	10.4	11.0	32.1	28.2	7.8	23.5	13.5	17.6	8.2	11.1	5.1	16.1	20.8	22.9	29.5	14.4	19.7	71.7	15.5	6.9	13.3	17.7	15.3	13.7	16.5	8.3	9.2	18.3	6.1	13.3	19.0	16.4	13.6	3.8	27.1	7.3	9.2	6.4	8.9	19.4	26.9	13.3	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2	26.8	37.6	86.9	79.0	57.4	21.4	7.6	91.7	29.4	39.8	45.4	15.7	102.5	94.5	158.8	26.8	57.1	173.6	23.3	181.6	135.6	85.0	78.7	25.3	85.9	223.6	25.4	127.8	76.1	277.9	55.5	84.0	130.9	70.9	196.6	120.1	61.4	172.0	171.9	65.0	148.8	22.8	51.8	55.6	36.4	23.4	84.1	88.0	79.9	140.5	131.2
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 209.3;Hepatocytes: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		NA	NA		20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	29.8	12.5	4.7	15.5	31.2	23.1	38.3	12.3	16.7	13.4	22.0	10.3	13.9	9.4	25.8	19.0	29.7	7.1	6.5	25.9	15.8	11.5	8.7	19.9	21.2	10.6	25.8	17.4	1.1	29.1	16.7	15.6	24.8	36.0	8.0	9.8	0.0	12.6	21.5	1.8	5.0	9.6	21.4	0.9	20.1	7.1	22.0	3.0	19.5	9.4	2.8	18.4	26.9	28.2	41.0	22.9	8.8	6.6	0.7	19.9	10.2	17.6	10.4	8.0	11.7	15.4	32.5	15.3	8.5	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5	86.4	31.4	19.9	24.0	15.9	8.1	140.8	50.9	14.7	10.3	15.7	9.8	71.5	74.6	42.0	24.0	10.7	74.3	0.0	209.3	136.9	28.0	18.3	4.7	186.6	22.2	0.0	12.6	16.0	18.3	5.2	20.4	10.7	25.3	32.5	40.1	54.2	92.3	23.0	35.7	59.8	10.7	12.9	17.9	4.7	7.5	15.8	49.2	21.8	71.1	13.6
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628424-107651026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043760, HPA051269"	Uncertain		Approved	Vesicles		NA	NA		140000	Vesicles		"HPA043760: AB_2678656, HPA051269: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	16.8	19.0	18.8	18.7	22.4	33.5	13.0	27.0	30.3	13.5	12.1	20.5	7.0	7.3	16.6	10.4	11.8	17.6	9.6	19.9	19.0	26.5	18.5	45.1	14.9	25.4	21.8	17.5	21.4	17.8	20.0	18.2	10.0	26.9	14.9	12.4	15.0	11.2	12.4	31.2	8.4	10.8	20.0	19.3	19.4	10.8	11.3	13.6	32.3	29.9	11.3	28.6	16.9	10.7	18.2	8.5	12.6	8.7	14.4	22.1	11.6	20.7	30.8	13.7	15.8	7.6	6.0	4.7	61.1	12.7	34.7	29.4	13.3	8.9	34.2	26.4	22.2	24.9	8.5	40.8	12.6	35.7	16.9	25.4	18.2	30.7	17.3	7.0	33.7	13.6	6.8	7.4	21.0	13.8	23.3	11.9	24.7	29.0	41.5	16.0	11.1	22.8	18.2	49.6	17.5	26.7	26.6	22.0	27.5	13.6	11.9	22.6	12.1	30.3	18.3	12.3	26.8	8.4	14.1	7.1	22.6	10.6	24.7	24.2	14.2	23.1	37.4	11.7	36.6	14.1	4.8	5.2	12.6	15.7	8.2	17.6	17.0	19.7	19.3	6.2	18.2	22.1	18.7	3.1	14.4	8.7	8.5	20.1	11.6	18.8	22.4	27.0	30.3	19.0	26.5	21.8	17.5	26.9	13.6	6.0	10.6	39.3	13.5	27.6	29.0	9.5	12.7	30.8	12.5	15.7	3.9	8.6	21.6	12.6	0.6	12.2	1.6	0.0	17.6	10.9	22.4	16.3	25.5	52.0	30.0	14.3	15.5	10.4	11.7	2.6	13.0	19.1	25.3	34.3	5.4	18.6	15.4	3.5	15.9	23.1	12.2	0.0	40.6	3.1	9.7	19.4	1.5	49.0	6.4	8.4
PRPS1L1	"PRPS3, PRPSL"	ENSG00000229937	"Phosphoribosyl pyrophosphate synthetase 1-like 1"	P21108	7	18026774-18027863	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 38.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 39.0;Spermatocytes: 72.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;K-562: 2.1"									HPA051269			Uncertain	Vesicles		NA	NA			Vesicles		"HPA051269: "					"unprognostic (2.39e-2)"									"unprognostic (3.18e-2)"	"unprognostic (1.11e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.7	0.3	0.6	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.4	0.3	0.6	0.8	0.9	0.5	0.1	0.4	1.1	0.7	0.1	0.6	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	6.5	0.0	72.2	1.3	0.0	0.0	0.0	0.0	0.0
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.1;testis: 109.7"	"Group enriched"	"Detected in many"	21	"Leydig cells: 1325.5;Peritubular cells: 1875.4;Sertoli cells: 614.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	5.4	20.8	4.0	10.2	8.7	6.1	6.1	3.7	11.5	18.7	13.3	5.7	44.4	4.1	17.0	21.7	9.6	9.6	13.2	3.3	4.0	3.5	10.8	9.0	5.4	10.7	2.7	7.7	75.3	19.9	20.1	2.4	3.2	2.9	14.9	10.2	4.4	11.1	138.1	1.5	10.3	6.3	12.2	3.9	7.6	14.3	109.7	3.1	26.2	7.8	5.5	10.9	15.1	10.2	21.9	17.7	10.5	12.5	15.0	22.7	16.7	31.3	20.8	7.2	13.1	8.9	10.6	4.1	15.6	8.6	17.3	16.9	14.7	25.2	9.2	7.1	7.5	14.8	23.8	14.0	17.1	20.4	24.7	30.1	11.3	17.1	13.6	8.3	22.3	11.7	10.2	11.5	12.9	17.1	8.9	7.0	26.8	8.3	12.9	14.6	21.6	34.0	10.3	15.4	25.5	28.1	18.2	31.1	23.5	10.4	26.1	14.0	9.4	18.9	0.7	11.8	10.4	18.8	10.1	6.5	13.7	9.9	49.9	16.6	30.3	11.1	21.9	14.3	11.3	21.4	10.5	12.5	5.6	11.7	12.4	13.6	18.0	17.0	11.1	17.7	21.9	22.7	15.3	5.5	15.0	7.7	12.6	14.0	16.7	4.0	8.7	3.7	11.5	4.0	3.5	2.7	7.7	2.9	3.1	3.0	5.4	25.1	40.7	56.8	0.6	1.6	5.1	21.4	5.7	52.4	0.0	0.6	61.3	17.7	9.4	10.8	8.4	23.3	33.8	5.7	24.8	42.5	27.6	13.9	22.0	0.0	20.9	11.6	18.7	23.3	1325.5	24.5	38.8	20.8	26.7	0.3	28.8	5.8	1875.4	8.7	0.0	614.4	21.7	4.9	5.8	38.1	0.3	29.3	48.2	31.1
RBKS	"DKFZp686G13268, RBSK"	ENSG00000171174	Ribokinase	Q9H477	2	27781364-27891098	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 57.6;Proximal tubular cells: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019725, HPA028285"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA019725: AB_1856105, HPA028285: AB_10601480"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.15e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.27e-2)"	14.4	22.2	2.5	2.4	5.2	4.1	2.2	2.1	4.1	2.6	3.0	1.7	4.9	12.4	4.7	4.7	3.1	7.4	10.7	3.5	3.7	4.3	15.1	22.6	10.4	0.8	3.0	2.4	24.2	2.4	3.5	10.3	6.2	12.3	6.9	2.4	2.2	1.4	16.8	7.6	1.0	11.8	3.8	4.7	1.7	1.6	4.8	1.4	0.3	4.5	2.8	1.1	4.8	12.0	5.8	5.1	5.6	3.8	4.9	6.5	3.4	3.1	2.1	0.3	0.4	0.4	0.7	2.1	0.8	0.6	0.4	0.6	4.8	1.5	1.1	10.5	1.7	1.5	1.3	0.2	1.0	0.8	0.4	0.2	0.1	0.5	4.1	1.6	0.9	0.2	1.0	1.7	2.7	3.7	0.7	0.6	1.9	0.1	1.3	2.0	4.1	0.7	2.3	0.0	2.1	1.7	0.9	0.2	0.7	22.1	0.2	0.9	1.2	2.9	4.0	1.7	1.1	1.8	4.6	0.2	0.7	0.5	1.9	1.2	6.7	7.9	2.1	1.9	3.1	0.1	5.6	3.8	1.9	3.0	1.6	6.1	5.8	4.0	6.5	5.1	4.6	4.2	3.6	5.6	4.9	0.8	0.8	5.8	3.4	2.5	5.2	2.1	4.1	3.7	4.3	3.0	2.4	12.3	1.4	6.0	5.3	1.9	2.8	1.8	10.3	6.4	2.5	57.6	7.9	17.4	3.9	3.3	39.7	9.3	26.8	4.1	18.8	0.0	11.1	1.1	1.9	1.1	2.3	25.3	5.5	7.9	3.5	1.8	1.8	21.9	1.4	7.2	1.7	2.8	3.2	12.1	7.7	7.0	2.5	88.0	18.7	0.0	2.1	15.4	14.5	1.4	1.3	5.0	6.4	1.7
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	20.6	26.8	17.4	17.5	28.3	27.4	29.9	27.2	21.8	25.9	34.8	38.5	31.7	13.9	17.9	21.0	35.1	20.3	25.6	29.0	39.6	16.7	18.1	25.8	39.3	35.9	38.6	27.3	19.9	19.2	28.9	29.7	38.7	23.6	33.7	13.9	25.9	19.4	21.2	32.9	14.8	23.8	25.5	41.7	19.6	18.7	20.8	19.9	29.9	30.9	20.9	12.0	23.0	22.5	18.2	32.8	19.4	31.4	27.6	34.8	23.2	16.9	25.1	11.7	14.8	29.9	25.2	27.0	22.5	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7	6.0	6.9	14.7	13.5	14.7	12.5	5.3	7.6	13.4	19.4	17.4	19.6	32.4	26.6	20.5	8.8	11.9	12.3	23.3	15.1	36.8	15.5	12.1	5.8	15.5	33.1	9.5	9.8	17.2	17.6	9.3	10.3	20.4	13.5	16.2	14.2	8.2	17.4	14.0	13.8	37.0	12.9	6.5	14.1	16.4	16.1	17.8	21.4	11.4	18.9	12.0
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.1"									"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.7	0.2	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2											0.0	0.0	0.0	0.1	0.1	2.9	1.5	0.0	0.0	1.2	0.0	7.9	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.2	0.3	0.3	0.0	0.7	0.0
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cytotrophoblasts: 210.0;Syncytiotrophoblasts: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.1	7.2	7.4	22.4	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	10.9	5.2	12.7	4.0	12.5	20.7	16.5	17.5	3.2	17.6	7.3	32.0	12.9	6.8	3.4	7.0	11.0	3.9	11.1	23.4	18.7	7.6	7.4	13.4	35.1	28.1	9.2	28.4	8.3	18.4	12.1	10.7	6.5	13.8	7.3	8.3	5.7	7.4	11.0	5.8	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.8	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6	11.9	10.4	45.3	15.3	33.2	8.7	11.4	15.3	2.7	3.4	19.2	2.0	210.0	8.3	13.5	6.8	26.6	15.2	70.0	30.1	69.7	29.7	21.6	21.8	5.9	38.8	12.7	18.4	17.8	15.5	2.6	18.4	22.5	38.8	25.2	24.7	4.3	21.4	28.1	17.7	12.9	5.1	19.4	18.0	25.3	32.5	35.8	188.7	37.3	56.2	35.5
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 7874.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.1"	"Group enriched"	"Detected in all"	9	"granulocytes: 206.1;monocytes: 136.4"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 71.7;hTERT-HME1: 110.3;RPTEC TERT1: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported					NA	NA					"CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781"	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	93.5	40.5	34.2	73.0	60.5	177.2	57.2	14.2	38.9	49.2	56.5	24.6	143.2	82.2	43.9	51.9	56.9	36.8	80.6	81.5	53.7	27.7	79.2	116.1	163.6	67.3	31.9	22.2	26.5	32.3	19.3	74.4	185.7	100.2	51.0	49.9	39.3	110.6	173.3	14.4	25.4	65.5	23.5	100.8	108.6	64.5	25.6	27.1	23.0	102.7	41.1	60.6	52.4	29.6	7.3	19.0	206.1	136.4	1.8	13.2	34.6	7.8	15.9	4.0	6.3	34.7	14.2	11.1	11.6	19.5	2.9	6.7	7.5	23.4	13.1	21.3	2.7	23.0	12.0	2.1	71.7	10.5	4.3	9.7	6.3	6.9	63.8	44.6	6.1	6.1	29.3	54.8	22.4	110.3	26.4	23.8	2.1	2.6	11.6	8.3	7.5	4.4	27.8	2.7	58.2	7.4	3.8	2.6	15.7	91.8	16.2	1.1	1.2	11.8	27.0	22.9	31.0	4.1	1.3	8.9	23.6	1.1	14.1	5.7	4.9	1.1	2.9	14.0	3.6	4.4	25.8	42.0	26.9	4.1	110.5	2.6	7.3	4.9	3.3	19.0	4.7	2.9	3.3	206.1	1.8	136.4	9.4	13.2	34.6	34.2	60.5	14.2	38.9	53.7	27.7	31.9	22.2	100.2	27.1	681.9	1577.9	669.2	3441.7	2163.0	54.6	354.3	471.3	1632.8	1773.2	786.9	110.0	750.1	1008.0	3727.8	14.4	551.6	1333.1	116.8	2669.2	833.7	892.9	4814.5	834.3	777.3	2012.7	68.3	506.3	417.4	3440.6	24.5	153.1	4222.2	3720.0	7874.9	746.4	527.6	2965.8	1220.5	86.7	1310.6	93.3	148.8	597.4	8.8	12.4	1283.5	2409.3	467.7	552.1	4788.0
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 851.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced					NA	NA					"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	11.3	43.9	14.8	6.3	16.7	6.4	11.0	11.3	17.4	12.5	33.4	9.2	10.8	51.5	11.7	14.9	8.9	10.2	11.3	14.5	13.4	9.8	49.6	73.2	9.1	8.9	18.3	17.1	19.9	20.0	11.3	13.7	5.5	15.2	11.5	9.2	13.9	16.2	13.6	12.0	7.9	47.9	10.1	10.5	12.5	13.3	11.7	16.8	2.7	18.5	11.9	7.3	9.9	13.3	8.6	18.4	5.5	25.6	6.6	11.8	12.9	7.5	11.7	10.2	19.4	15.2	18.8	1.3	5.4	18.6	11.7	15.2	3.8	3.9	1.5	3.1	5.1	13.9	6.8	6.4	5.1	7.5	2.2	19.5	1.7	6.3	19.4	19.8	0.0	5.5	24.5	12.5	6.9	4.8	14.9	17.2	1.6	1.0	2.4	12.4	0.6	0.1	1.6	4.1	4.4	8.0	3.0	5.1	1.8	17.6	8.7	1.1	10.2	5.2	10.3	9.7	9.0	6.5	1.7	8.4	5.6	4.1	0.1	7.8	5.0	4.3	0.2	20.1	2.3	8.6	4.6	25.6	5.5	8.9	17.1	10.5	8.6	7.7	9.1	18.4	8.3	11.8	8.4	1.6	6.6	8.8	8.3	11.2	12.9	14.8	16.7	11.3	17.4	13.4	9.8	18.3	17.1	15.2	16.8	41.7	99.3	62.4	77.5	73.4	114.0	50.8	193.6	53.5	58.0	76.8	64.8	62.2	358.1	104.4	10.1	65.2	92.1	0.0	57.1	27.9	82.7	93.0	60.1	279.6	138.9	122.3	127.3	98.8	132.8	13.8	168.2	127.9	89.4	60.5	87.9	109.7	92.6	97.9	112.1	851.6	143.3	71.1	82.1	26.5	3.6	49.1	66.2	70.8	92.5	80.2
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608262-3636322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA		150000	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: AB_2685388"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	8.9	12.9	7.6	6.2	10.6	5.9	8.9	17.3	12.3	8.8	14.1	14.9	8.8	18.5	10.7	6.1	11.6	7.6	5.3	5.9	7.0	5.5	14.3	26.7	6.3	5.3	12.0	4.5	10.2	13.7	11.8	6.2	8.6	9.8	7.4	8.6	12.3	8.9	9.4	7.5	12.1	22.8	5.1	6.7	6.1	9.7	5.2	13.0	7.7	7.7	4.0	7.6	7.5	9.6	5.2	7.1	5.1	4.8	6.4	7.5	5.4	5.3	10.9	11.6	7.4	4.8	4.9	6.4	3.6	3.2	7.0	4.2	18.7	5.0	6.3	8.0	6.9	6.6	10.4	15.4	11.6	5.1	10.1	15.0	6.9	9.3	13.4	5.8	5.9	9.8	8.2	5.6	7.8	5.3	6.0	13.2	5.0	9.1	8.1	6.8	9.5	7.6	4.6	5.8	12.3	7.3	10.5	6.1	10.1	10.0	6.9	3.3	8.9	13.1	12.1	3.6	7.4	10.8	3.5	9.4	10.8	5.1	10.3	8.7	2.7	3.5	4.2	11.7	5.4	5.4	3.3	4.7	5.1	4.6	4.8	4.7	5.2	4.2	3.7	6.5	4.0	7.5	4.7	0.9	6.4	4.1	7.1	3.6	5.4	7.6	10.6	17.3	12.3	7.0	5.5	12.0	4.5	9.8	13.0	0.0	2.7	1.5	0.8	0.0	5.4	0.8	7.6	1.4	1.2	5.2	15.7	8.1	1.7	2.9	0.4	2.2	10.5	0.0	4.1	8.6	0.9	1.9	0.0	14.8	6.9	14.3	3.4	1.8	1.3	0.0	3.7	2.5	0.0	3.6	5.9	3.1	4.3	5.8	2.5	6.5	15.6	0.0	0.8	0.6	1.2	0.4	4.7	1.0	5.5	1.7
ST20	HCCS-1	ENSG00000180953	"Suppressor of tumorigenicity 20"	Q9HBF5	15	79898840-79923702	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 69.3"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 18.6;neutrophil: 69.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 69.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.7"															NA	NA						"unprognostic (2.48e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.35e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (7.69e-8)"	"unprognostic (6.49e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.19e-2)"	7.5	5.4	9.9	15.0	10.7	7.9	8.6	15.4	8.0	5.5	8.2	6.4	4.5	4.0	6.5	16.3	6.0	8.3	10.3	9.3	8.8	8.2	12.3	23.1	12.7	13.1	10.8	5.3	7.1	6.2	9.2	12.7	7.7	10.1	13.3	5.4	8.6	11.5	8.4	5.6	12.6	9.8	5.4	10.7	22.9	5.5	10.8	6.1	9.0	12.2	5.7	10.5	5.5	10.1	4.0	3.0	69.3	5.3	3.9	2.1	2.6	4.8	10.4	4.4	5.5	7.6	6.4	10.0	5.0	3.3	2.6	3.3	2.2	7.9	6.1	3.3	3.6	8.6	8.3	9.2	2.8	1.9	8.6	8.6	6.9	7.1	3.4	7.2	2.5	3.9	7.2	3.9	1.8	5.4	7.3	2.8	11.1	5.9	3.6	4.0	15.8	3.5	17.9	10.4	14.9	6.9	5.1	1.4	3.8	6.6	4.0	6.6	7.2	9.8	6.1	28.7	12.0	5.1	16.5	3.6	6.7	1.8	0.0	4.1	4.1	20.0	9.2	5.2	14.3	3.4	0.5	3.9	18.6	1.9	2.2	1.5	4.0	2.1	2.1	3.0	3.8	2.1	1.9	69.3	3.9	5.3	1.8	1.8	2.6	9.9	10.7	15.4	8.0	8.8	8.2	10.8	5.3	10.1	6.1	6.0	17.0	5.4	6.4	4.2	7.1	10.4	2.5	6.7	5.7	14.0	7.9	10.0	19.9	15.2	10.0	3.8	9.6	0.0	10.4	9.3	6.1	9.1	6.9	35.0	35.3	1.6	18.6	6.2	11.2	3.6	6.6	12.0	5.0	137.1	10.6	7.7	12.5	17.3	4.6	32.7	4.4	6.5	3.8	19.4	20.6	3.8	36.0	6.4	10.0	3.9
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Cell type enhanced"	"Detected in all"	6	"monocytes: 1009.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	42.2	53.5	15.5	29.3	32.1	18.7	45.7	32.1	41.4	31.8	26.3	22.7	92.2	23.6	43.7	42.1	24.6	45.7	24.5	34.7	16.6	30.8	49.7	40.8	20.7	79.4	34.3	65.2	60.9	15.3	28.0	21.4	17.4	23.0	43.7	29.8	52.9	39.5	29.5	40.4	37.9	77.3	24.3	62.0	43.4	31.6	18.2	84.5	57.8	24.6	38.3	13.4	30.0	62.0	31.1	14.4	29.4	49.6	58.0	14.6	13.7	11.5	30.1	16.7	16.2	28.0	32.4	57.0	58.9	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0	131.0	100.4	88.6	136.2	65.4	45.6	40.9	122.3	141.8	86.4	143.1	13.7	355.3	212.2	199.7	61.7	74.4	141.1	280.4	236.4	383.3	78.6	213.8	155.0	128.2	368.8	47.7	97.4	79.8	301.9	17.2	109.0	235.0	133.3	1009.1	137.9	126.1	238.1	181.4	97.9	218.5	43.3	71.1	73.5	122.7	154.7	72.6	440.3	79.1	199.9	251.7
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 587.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.4	159.3	22.8	25.3	50.9	62.2	46.6	21.3	37.0	37.0	35.4	44.0	81.1	39.6	10.3	31.1	71.5	45.6	39.5	80.3	11.0	13.2	21.9	26.4	111.4	66.0	62.3	32.2	17.8	45.0	46.2	44.2	22.8	101.2	46.5	33.7	18.7	17.3	15.0	38.5	33.6	36.1	77.4	61.4	38.5	20.3	10.4	73.6	57.8	53.5	14.8	11.0	39.7	63.6	38.3	72.9	19.8	44.6	34.8	11.4	17.7	33.7	40.7	10.0	18.7	23.7	25.0	32.7	21.2	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3	125.0	107.1	122.7	318.5	70.5	32.5	12.0	68.8	60.2	69.4	59.3	27.5	317.9	68.0	167.6	5.0	48.1	125.0	23.3	233.6	204.0	47.6	102.3	61.2	73.1	233.2	35.0	50.5	56.4	587.5	2.7	145.6	247.7	72.6	160.5	113.7	78.1	222.7	69.1	100.4	170.5	36.1	51.8	72.1	14.1	21.1	58.6	345.9	84.1	213.7	357.0
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 515.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Cell line enriched"	"Detected in single"	157	"THP-1: 102.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	102.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	23.8	0.0	0.0	0.0	16.9	3.7	1.3	0.0	0.0	0.0	5.3	0.0	0.0	1.8	0.0	1.1	25.8	1.4	35.6	515.6	0.1	0.0	0.5	0.0	0.0
TKTL2	"DKFZP434L1717, FLJ32975"	ENSG00000151005	"Transketolase like 2"	Q9H0I9	4	163471093-163473746	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 66.8"	"Group enriched"	"Detected in some"	19	"Early spermatids: 47.2;Late spermatids: 27.7;Spermatocytes: 100.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"			"unprognostic (8.62e-2)"			"unprognostic (2.05e-2)"		"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"		"unprognostic (7.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	100.1	1.6	0.0	0.0	0.0	0.0	0.0
